Expertise in
21
conditions

Dr. Anusha K. Kalbasi

Radiation Oncology
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
21
conditions
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 

Overview

Anusha Kalbasi is a Radiation Oncologist practicing medicine in Palo Alto, California.

Dr. Kalbasi is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, and Undifferentiated Pleomorphic Sarcoma.

He is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 3 clinical trials.

Specialties

Radiation Oncology

Licenses

Internal Medicine in PA

Hospital Affiliations

Stanford Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sutter Health
  • HMO
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Stanford University
875 Blake Wilbur Dr, Palo Alto, CA 94304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase I Dose Escalation Study of Systemically Administered IL13Ra2 Chimeric Antigen Receptor (CAR) T Cells After a Nonmyeloablative Conditioning Regimen in Patients With Metastatic Melanoma and Other Solid Tumors
Phase I Dose Escalation Study of Systemically Administered IL13Ra2 Chimeric Antigen Receptor (CAR) T Cells After a Nonmyeloablative Conditioning Regimen in Patients With Metastatic Melanoma and Other Solid Tumors
Enrollment Status: Recruiting
Publish Date: March 17, 2026
Intervention Type: Drug, Procedure, Biological, Other
Study Drugs: Cyclophosphamide, Fludarabine Phosphate, IL13Ralpha2-Specific Hinge-Optimized 4-1BB-co-Stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells, Recombinant Interleukin-2
Study Phase: Phase 1
Study of CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR)-T Cells for the Treatment of Relapsed or Refractory B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CD20 - Cluster of Differentiation Antigen 20)
Study of CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR)-T Cells for the Treatment of Relapsed or Refractory B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CD20 - Cluster of Differentiation Antigen 20)
Enrollment Status: Active_not_recruiting
Publish Date: August 20, 2026
Intervention Type: Drug, Biological
Study Drugs: Cyclophosphamide, Fludarabine, Tocilizumab, CD19/CD20 CAR-T Cell Therapy
Study Phase: Phase 1
A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue Sarcoma
A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue Sarcoma
Enrollment Status: Active_not_recruiting
Publish Date: March 10, 2026
Intervention Type: Biological, Procedure, Radiation
Study Drugs: Immunotherapeutic Agent, Nivolumab
Study Phase: Phase 1
View 2 Less Clinical Trial

73 Total Publications

Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.
Journal: Science (New York, N.Y.)
Published: February 19, 2026
Similar Doctors
Expertise in
15
conditions
Dr. Richard T. Hoppe
Radiation Oncology
Expertise in
15
conditions
Dr. Richard T. Hoppe
Radiation Oncology
Referral may be required

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (1.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richard Hoppe is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Hoppe is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Mycosis Fungoides, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Cutaneous T-Cell Lymphoma (CTCL).

Expertise in
9
conditions
Dr. Maximilian Diehn
Radiation Oncology
Expertise in
9
conditions
Dr. Maximilian Diehn
Radiation Oncology
Referral may be required

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (0.1 miles away)
650-723-6171
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maximilian Diehn is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Diehn is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

Expertise in
45
conditions
Dr. Scott G. Soltys
Radiation Oncology
Expertise in
45
conditions
Dr. Scott G. Soltys
Radiation Oncology
Referral may be required

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (0.1 miles away)
650-724-1569
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Scott Soltys is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Soltys is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Metastatic Brain Tumor, Astrocytoma, Acoustic Neuroma, and Rhizotomy.

Frequently Asked Questions about Dr. Anusha K. Kalbasi

How do I make an appointment with Dr. Anusha K. Kalbasi?

You can book an appointment with Dr. Anusha K. Kalbasi by calling their office at 650-498-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Anusha K. Kalbasi a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anusha K. Kalbasi is classified as an Elite expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Anusha K. Kalbasi specialize in?

While Dr. Anusha K. Kalbasi is a Radiation Oncology, they have specific expertise in Adult Soft Tissue Sarcoma, Liposarcoma, and Fibrosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Anusha K. Kalbasi participate in research or clinical trials?

Yes. Dr. Anusha K. Kalbasi has published 73 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Dr. Anusha K. Kalbasi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Anusha K. Kalbasi accept my insurance?

Dr. Anusha K. Kalbasi accepts most major insurance plans, including Anthem BCBS and Blue Shield of California. We recommend calling the office directly at 650-498-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kalbasi's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 10 Advanced Conditions
View All 55 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile